in vitro News and Research

RSS

Novel plasma medicine with anti-tumor effect discovered

Nagoya University researchers develop cold plasma-activated Ringer's solution for chemotherapy. The solution has anti-tumor effects in vitro and in vivo that derive from the lactate component.

14 Dec 2016

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.

9 Dec 2016

Research reveals opposing role for SNAP23 protein in endocrine and exocrine pancreas

Movement of secretory molecules, such as hormones and digestive enzymes, out of the cell is known as exocytosis. This process is guided by SNARE proteins, which help the fusion of secretory vesicles with the plasma membrane.

8 Dec 2016

Synthetic sgRNA for CRISPR genome editing

Chemically synthesized single guide RNA is the best way to do CRISPR genome editing. It is more pure than biological methods of creating guide RNAs, like in vitro transcription or plasmids. As a result, sgRNA leads to more consistency and higher quality.

8 Dec 2016

Empa researchers developing solution to magnetically remove bacteria from blood

Blood poisoning is still fatal in more than 50% of cases, but can be cured if treated at an early stage. The highest priority is therefore to act quickly.

8 Dec 2016

New SFU research could revolutionize IVF success rates

Over the past three years, Canadian women desperate to conceive a child endured more than 82,000 attempts to become impregnated using in vitro fertilization (IVF), a reproductive technique that fertilizes a woman's eggs outside of her body.

7 Dec 2016

Queen's University expert to lead new €4m initiative for assessing impact of chemicals on health

A Queen's University Belfast expert is leading a €4m international initiative to investigate whether natural toxins and manmade chemicals are creating potentially dangerous mixtures that affect our natural hormones and cause major illnesses such as cancer, obesity, diabetes or infertility.

7 Dec 2016

VIB scientists reveal how NLRP2 protein plays key role in early embryogenesis and fertility

Led by Prof. Mohamed Lamkanfi (VIB-Ghent University), researchers have demonstrated in animal models that a protein called NLRP2 plays an important role in early embryogenesis, the process of cell division in fertilized eggs that occurs before they implant into the lining of the uterus.

6 Dec 2016

Endometrial microbiota play vital role in determining reproductive outcome in women undergoing IVF

Endometrial microbiota (bacteria in the uterine cavity) play an important role in determining whether women are able to get pregnant via in vitro fertilization (IVF), according to a new study published in the American Journal of Obstetrics and Gynecology.

6 Dec 2016

UC San Diego scientists reveal surprising role for Hippo pathway in subduing tumor immunogenicity

Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings, published in Cell on December 1, could have a clinical role in improving efficiency of immunotherapy drugs.

1 Dec 2016

Monell Center receives Gates Foundation grant to support innovative global health research project

The Monell Center announced today that it has received a $345,000 grant from the Bill & Melinda Gates Foundation. The grant supports an innovative global health research project titled, "Developing Novel Pediatric Formulation Technologies for Global Health: Human Taste Assays."

1 Dec 2016

biosurfit announces CE Marking for new HbA1c test

Today, biosurfit SA, the in vitro point-of-care (PoC) diagnostics company, announces CE Marking (Conformité Européenne) for its HbA1c (Haemoglobin A1c) test, the third in a series of tests available on its spinit point-of-care instrument.

1 Dec 2016

Scientists synthesize antitumor compound to combat chemoresistant cancer

A team of scientists from N. D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences, N. K. Kol'tsov Institute of Developmental Biology of the RAS, and Immune Pharmaceuticals LLC led by MIPT's Prof. Alexander Kiselyov has synthesized an antitumor compound that could be used to fight chemoresistant cancer.

30 Nov 2016

Particle Works develops hydrogel beads to enable 3D cell culture growth

Particle Works – the nano- and microstructured material specialist – has developed a range of alginate and agarose hydrogel beads designed to enable three dimensional cell culture growth.

30 Nov 2016

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year.

29 Nov 2016

Research reveals key role of fibroblasts in development of rheumatoid arthritis

A study led by researchers at the University of Birmingham reveals the key role of different types of fibroblast cells in the development of rheumatoid arthritis (RA), opening up a new avenue for research into treatment of the disease.

23 Nov 2016

Pitt researcher finds way to regenerate heart tissues in mammals

Many lower forms of life on earth exhibit an extraordinary ability to regenerate tissue, limbs, and even organs--a skill that is lost among humans and other mammals.

23 Nov 2016

Noninvasive biomedical imaging technology uses light to map the brain

Scientific progress has provided a solid understanding of the anatomy of the brain. However, there is still no reliable way to examine neuron to neuron communication, as it happens--a key to understanding the correlation between brain structure and brain function.

22 Nov 2016

De-risking drug development free webinar from Envigo

De-risking represents a relatively new but developing strategy designed to quickly assess if a new drug has a liability. Knowing your compound’s risk for drug-to-drug interactions (DDI), drug induced liver injury (DILI) and metabolites in safety testing (MIST) early on in drug development, leads to greater confidence and added value on your molecule’s journey to market.

18 Nov 2016

New method to generate kidney organoids from patient cells can help study human kidney diseases

A new method to create kidney organoids from patient cells may provide insights into how kidney diseases arise and how they should be treated.

18 Nov 2016

in vitro News and Research

Novel plasma medicine with anti-tumor effect discovered

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

Research reveals opposing role for SNAP23 protein in endocrine and exocrine pancreas

Synthetic sgRNA for CRISPR genome editing

Empa researchers developing solution to magnetically remove bacteria from blood

New SFU research could revolutionize IVF success rates

Queen's University expert to lead new €4m initiative for assessing impact of chemicals on health

VIB scientists reveal how NLRP2 protein plays key role in early embryogenesis and fertility

Endometrial microbiota play vital role in determining reproductive outcome in women undergoing IVF

UC San Diego scientists reveal surprising role for Hippo pathway in subduing tumor immunogenicity

Monell Center receives Gates Foundation grant to support innovative global health research project

biosurfit announces CE Marking for new HbA1c test

Scientists synthesize antitumor compound to combat chemoresistant cancer

Particle Works develops hydrogel beads to enable 3D cell culture growth

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

Research reveals key role of fibroblasts in development of rheumatoid arthritis

Pitt researcher finds way to regenerate heart tissues in mammals

Noninvasive biomedical imaging technology uses light to map the brain

De-risking drug development free webinar from Envigo

New method to generate kidney organoids from patient cells can help study human kidney diseases

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News